Cargando…

An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach

BACKGROUND: Legislative requirements for Marketing Authorisation Holders (MAHs) to maintain a Pharmacovigilance System Master File (PSMF) were introduced in the European Union (EU) in 2010, operationalised in 2012 and subsequently introduced in other territories. There are no internationally agreed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavery, Clare, Emmott, Joanne, Jeck-Thole, Sabine, Rouben, Pascale, Usher, Dionne, van der Spuij, Willemijn, Woodward, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334448/
https://www.ncbi.nlm.nih.gov/pubmed/35723862
http://dx.doi.org/10.1007/s40290-022-00422-2
_version_ 1784759107595534336
author Lavery, Clare
Emmott, Joanne
Jeck-Thole, Sabine
Rouben, Pascale
Usher, Dionne
van der Spuij, Willemijn
Woodward, Louise
author_facet Lavery, Clare
Emmott, Joanne
Jeck-Thole, Sabine
Rouben, Pascale
Usher, Dionne
van der Spuij, Willemijn
Woodward, Louise
author_sort Lavery, Clare
collection PubMed
description BACKGROUND: Legislative requirements for Marketing Authorisation Holders (MAHs) to maintain a Pharmacovigilance System Master File (PSMF) were introduced in the European Union (EU) in 2010, operationalised in 2012 and subsequently introduced in other territories. There are no internationally agreed standards for the PSMF and country/regional requirements vary, leaving room for interpretation. This creates complexities for MAHs in implementing and maintaining multiple PSMFs. OBJECTIVES: The approaches taken towards the creation and maintenance of PSMFs in a global environment were investigated using a survey in order to gain a better understanding of the impact of the PSMF for MAHs. METHODS: A structured benchmarking survey was conducted during September and October of 2019 and the responses were analysed. A questionnaire with open-ended questions was designed to elicit detailed information on PSMF management and provide insights into company experiences. Companies affiliated to the EU Federation of Pharmaceutical Industries and Associations (EFPIA) and industry stakeholders with experience of PSMFs were contacted ensuring a broad representation including small, medium and large pharmaceutical companies, contract organisations/consultants and research-driven and generic organisations. RESULTS: Thirty companies responded; of these, 29 provided information relating to their PSMF practices. Respondents acknowledged that the PSMF is a valuable document that has helped to create greater awareness of pharmacovigilance within companies. Complex and varying international requirements were recognised as burdensome, especially in the context of consistent development and maintenance of multiple PSMFs. The respondents indicated that companies use the EU PSMF to manage requirements in other territories. Similar areas for standardisation were identified across respondents. CONCLUSION: The survey results highlight both the value of the PSMF and the challenges in maintaining it. Building on these responses, the paper offers pragmatic solutions to the challenges faced by MAHs and proposes a continued dialogue with key stakeholders in industry and national regulatory authorities about PSMF globalisation, harmonisation and simplification of requirements.
format Online
Article
Text
id pubmed-9334448
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-93344482022-07-30 An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach Lavery, Clare Emmott, Joanne Jeck-Thole, Sabine Rouben, Pascale Usher, Dionne van der Spuij, Willemijn Woodward, Louise Pharmaceut Med Original Research Article BACKGROUND: Legislative requirements for Marketing Authorisation Holders (MAHs) to maintain a Pharmacovigilance System Master File (PSMF) were introduced in the European Union (EU) in 2010, operationalised in 2012 and subsequently introduced in other territories. There are no internationally agreed standards for the PSMF and country/regional requirements vary, leaving room for interpretation. This creates complexities for MAHs in implementing and maintaining multiple PSMFs. OBJECTIVES: The approaches taken towards the creation and maintenance of PSMFs in a global environment were investigated using a survey in order to gain a better understanding of the impact of the PSMF for MAHs. METHODS: A structured benchmarking survey was conducted during September and October of 2019 and the responses were analysed. A questionnaire with open-ended questions was designed to elicit detailed information on PSMF management and provide insights into company experiences. Companies affiliated to the EU Federation of Pharmaceutical Industries and Associations (EFPIA) and industry stakeholders with experience of PSMFs were contacted ensuring a broad representation including small, medium and large pharmaceutical companies, contract organisations/consultants and research-driven and generic organisations. RESULTS: Thirty companies responded; of these, 29 provided information relating to their PSMF practices. Respondents acknowledged that the PSMF is a valuable document that has helped to create greater awareness of pharmacovigilance within companies. Complex and varying international requirements were recognised as burdensome, especially in the context of consistent development and maintenance of multiple PSMFs. The respondents indicated that companies use the EU PSMF to manage requirements in other territories. Similar areas for standardisation were identified across respondents. CONCLUSION: The survey results highlight both the value of the PSMF and the challenges in maintaining it. Building on these responses, the paper offers pragmatic solutions to the challenges faced by MAHs and proposes a continued dialogue with key stakeholders in industry and national regulatory authorities about PSMF globalisation, harmonisation and simplification of requirements. Springer International Publishing 2022-06-20 2022 /pmc/articles/PMC9334448/ /pubmed/35723862 http://dx.doi.org/10.1007/s40290-022-00422-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Lavery, Clare
Emmott, Joanne
Jeck-Thole, Sabine
Rouben, Pascale
Usher, Dionne
van der Spuij, Willemijn
Woodward, Louise
An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach
title An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach
title_full An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach
title_fullStr An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach
title_full_unstemmed An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach
title_short An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach
title_sort industry survey on managing the pharmacovigilance system master file in a global environment: the need for a pragmatic approach
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334448/
https://www.ncbi.nlm.nih.gov/pubmed/35723862
http://dx.doi.org/10.1007/s40290-022-00422-2
work_keys_str_mv AT laveryclare anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT emmottjoanne anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT jecktholesabine anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT roubenpascale anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT usherdionne anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT vanderspuijwillemijn anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT woodwardlouise anindustrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT laveryclare industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT emmottjoanne industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT jecktholesabine industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT roubenpascale industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT usherdionne industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT vanderspuijwillemijn industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach
AT woodwardlouise industrysurveyonmanagingthepharmacovigilancesystemmasterfileinaglobalenvironmenttheneedforapragmaticapproach